1. Tilray-Aphria deal closes, company to control biggest share of Cdn pot market - Business News  Castanet.net
  2. New Tilray CEO Irwin Simon discusses building a global cannabis brand  CNBC Television
  3. Tilray, Aphria Close Merger, Create The 'New' Tirlay  Benzinga
  4. With Aphria M&A Deal Closed, $TLRY CEO Plans Global Cannabis Brands  Bloomberg
  5. Tilray Stock Drops After Finalizing Merger with Aphira  Schaeffers Research
  6. View Full coverage on Google News
Tilray Inc. and Aphria Inc. say their merger deal has now closed after receiving approval from shareholders of both companies.Tilray Inc. and Aphria Inc. say their merger deal has now closed after receiving approval from shareholders of both companies.

Tilray-Aphria deal closes, company to control biggest share of Cdn pot market - Business News - Castanet.net

Bloomberg - Are you a robot?

Tilray (TLRY) is lower this morning after finalizing its merger with Aphria (APHA)

Tilray Stock Drops After Finalizing Merger with Aphira

Tilray, Inc. (NASDAQ: TLRY) and Aphria, Inc. (NASDAQ:Tilray, Inc. (NASDAQ: TLRY) and Aphria, Inc. (NASDAQ:

Tilray, Aphria Close Merger, Create The 'New' Tilray | Benzinga

Technical420 is dedicated to educating investors about the risk and rewards of investing in the cannabis industry. We highlight companies that have the most growth potential by utilizing our proprietary analytics platform.Technical420 is dedicated to educating investors about the risk and rewards of investing in the cannabis industry. We highlight companies that have the most growth potential by utilizing our proprietary analytics platform.

Tilray & Aphria Announce Closing of Transaction That Creates the “New” Tilray – a Global Cannabis Leader - Technical420 | Technical420

The combined company is taking the Tilray name.The combined company is taking the Tilray name.

The Aphria and Tilray Merger Finally Closes | The Motley Fool

Canadian cannabis company Tilray Inc. undefined said Monday its shares will continue to trade on Nasdaq under the ticker symbol "TLRY" after its merger with...Canadian cannabis company Tilray Inc. undefined said Monday its shares will continue to trade on Nasdaq under the ticker symbol "TLRY" after its merger with...

Tilray says shares will start trading on Toronto Stock Exchange from May 5 after Aphria merger approved - MarketWatch

After Tilray’s (TLRY) shareholders voted in favor of the proposed merger Aphria (APHA) last Friday, the two cannabis companies announced today the completion of the transaction. The combined company, which will operate under the Tilray name, will be the world’s largest cannabis company, with a market capitalization of approximately $8.2 billion. The combination of Aphria and Tilray is expected to generate roughly $81 million in annual pre-tax cost savings within 18 months of the transaction's completion. (See Tilray stock analysis on TipRanks) The company will continue to trade on the Nasdaq Global Select Exchange under the symbol "TLRY" and will commence trading on the Toronto Stock Exchange under the symbol "TLRY" on May 5. Under the terms, Aphria shareholders receive 0.8381 of a Tilray share for each common share of Aphria. Aphria’s CEO Irwin D. Simon will lead the company. Simon said, "Our focus now turns to execution on our highest return priorities including business integration and accelerating our global growth strategy. Covid-19 related lockdowns have presented unique challenges across Canadian and German markets. As these markets begin to re-open, Tilray is poised to strike and transform the industry with our highly scalable operational footprint, a curated portfolio of diverse medical and adult-use cannabis brands and products, a multi-continent distribution network, and a robust capital structure to fund our global expansion strategy and deliver sustained profitability and long-term value for our stakeholders." Last week, BofA Securities analyst Heather Balsky initiated coverage of the stock with a Buy rating and a $23.00 price target (26.2% upside potential). Balsky is bullish on the business and expects progress from the government to legalize marijuana at the federal level. Overall, Tilray stock scores a Hold consensus rating based on 1 Buy, 8 Holds, and 1 Sell. The average analyst price target of $24.29 implies an upside potential of about 33% from current levels. Related News: good natured Products Revenue Increases 65% In FY2020 The Green Organic Dutchman Gives Update On Operations Aphria Shareholders Approve Tilray Merger More recent articles from Smarter Analyst: General Motors To Invest $1B To Produce Electric Cars In Mexico Woven Acquisition To Help Slack Rival Microsoft And Google XPeng’s April Vehicle Deliveries Jump 285% AstraZeneca’s Farxiga Gets FDA Approval For Chronic Kidney DiseaseAfter Tilray’s (TLRY) shareholders voted in favor of the proposed merger Aphria (APHA) last Friday, the two cannabis companies announced today the completion of the transaction. The combined company, which will operate under the Tilray name, will be the world’s largest cannabis company, with a market capitalization of approximately $8.2 billion. The combination of Aphria and Tilray is expected to generate roughly $81 million in annual pre-tax cost savings within 18 months of the transaction's completion. (See Tilray stock analysis on TipRanks) The company will continue to trade on the Nasdaq Global Select Exchange under the symbol "TLRY" and will commence trading on the Toronto Stock Exchange under the symbol "TLRY" on May 5. Under the terms, Aphria shareholders receive 0.8381 of a Tilray share for each common share of Aphria. Aphria’s CEO Irwin D. Simon will lead the company. Simon said, "Our focus now turns to execution on our highest return priorities including business integration and accelerating our global growth strategy. Covid-19 related lockdowns have presented unique challenges across Canadian and German markets. As these markets begin to re-open, Tilray is poised to strike and transform the industry with our highly scalable operational footprint, a curated portfolio of diverse medical and adult-use cannabis brands and products, a multi-continent distribution network, and a robust capital structure to fund our global expansion strategy and deliver sustained profitability and long-term value for our stakeholders." Last week, BofA Securities analyst Heather Balsky initiated coverage of the stock with a Buy rating and a $23.00 price target (26.2% upside potential). Balsky is bullish on the business and expects progress from the government to legalize marijuana at the federal level. Overall, Tilray stock scores a Hold consensus rating based on 1 Buy, 8 Holds, and 1 Sell. The average analyst price target of $24.29 implies an upside potential of about 33% from current levels. Related News: good natured Products Revenue Increases 65% In FY2020 The Green Organic Dutchman Gives Update On Operations Aphria Shareholders Approve Tilray Merger More recent articles from Smarter Analyst: General Motors To Invest $1B To Produce Electric Cars In Mexico Woven Acquisition To Help Slack Rival Microsoft And Google XPeng’s April Vehicle Deliveries Jump 285% AstraZeneca’s Farxiga Gets FDA Approval For Chronic Kidney Disease

Tilray’s Merger With Aphria Closes, Creates Global Cannabis Leader

Please Wait... | Cloudflare

404 Not Found

Tilray, Inc. (“Tilray”) and Aphria Inc. (“Aphria”) today announced the completion of the previously announced business combination, ushering in a new Tilray, Inc. (“Tilray”) and Aphria Inc. (“Aphria”) today announced the completion of the previously announced business combination, ushering in a new

Tilray & Aphria Announce Closing of Transaction That Creates the “New” Tilray – a Global Cannabis Leader | Business Wire

nanaimonewsnow.com